1. Home
  2. LQDA vs LMND Comparison

LQDA vs LMND Comparison

Compare LQDA & LMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LQDA

Liquidia Corporation

N/A

Current Price

$47.98

Market Cap

4.0B

Sector

Health Care

ML Signal

N/A

Logo Lemonade Inc.

LMND

Lemonade Inc.

N/A

Current Price

$39.74

Market Cap

4.2B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
LQDA
LMND
Founded
2004
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Property-Casualty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
4.2B
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
LQDA
LMND
Price
$47.98
$39.74
Analyst Decision
Buy
Hold
Analyst Count
8
11
Target Price
$54.38
★ $56.33
AVG Volume (30 Days)
★ 3.9M
1.2M
Earning Date
11-10-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 51.81
21.40
EPS
★ 1.26
N/A
Revenue
$158,320,000.00
★ $737,900,000.00
Revenue This Year
$357.27
$67.61
Revenue Next Year
$1.34
$34.93
P/E Ratio
$35.40
★ N/A
Revenue Growth
★ 1031.18
40.15
52 Week Low
$22.31
$39.11
52 Week High
$93.61
$99.90

Technical Indicators

Market Signals
Indicator
LQDA
LMND
Relative Strength Index (RSI) 55.64 37.46
Support Level $35.00 N/A
Resistance Level $63.46 $47.31
Average True Range (ATR) 3.10 2.42
MACD 1.61 -0.32
Stochastic Oscillator 77.29 16.14

Price Performance

Historical Comparison
LQDA
LMND

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.

About LMND Lemonade Inc.

Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes. The company is using technology, data, artificial intelligence, contemporary design, and social impact to deliver delightful and affordable insurances. The Company operates in one report segment providing personal property and casualty insurance products within the United States and Europe, including the UK.

Share on Social Networks: